On October 1, 2009
Bayer to Onyx: You Don’t Even Know the Name of the Drug We Didn’t Steal From You
Bayer is arguing that it did not steal an analog of its Nexavar cancer drug from development partner Onyx because Onyx got the name of the analog wrong in its lawsuit. Onyx sued Bayer in May, alleging that after the little-cancer-company-that-could had shown Bayer how to make Nexavar (sorafenib), Bayer then secretly synthesized analogs of the drug and patented them without telling Onyx, in breach of their agreement.
0 Comments